Detalhe da pesquisa
1.
Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 5: 325-332, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34151132
2.
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
Clin Lung Cancer
; 22(3): e379-e389, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653295
3.
Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.
Clin Cancer Res
; 14(21): 7060-7, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981003
4.
EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas.
Clin Cancer Res
; 24(24): 6548-6555, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154228
5.
Tumor biomarker testing in non-small-cell lung cancer: A decade of change.
Lung Cancer
; 116: 90-95, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29413057
6.
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer.
J Thorac Oncol
; 13(7): 1037-1042, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29631035
7.
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.
PLoS Med
; 4(10): 1669-79; discussion 1680, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17973572
8.
Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers.
Lung Cancer
; 58(1): 95-103, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17610986
9.
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
Clin Cancer Res
; 12(13): 3908-14, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16818686
10.
Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.
J Thorac Oncol
; 12(5): 878-883, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104537
11.
Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.
Lung Cancer
; 106: 17-21, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285689
12.
EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
Clin Lung Cancer
; 17(6): 483-492, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27381270
13.
Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice.
Cancer Treat Commun
; 9: 41-43, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111612
14.
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.
J Thorac Oncol
; 11(6): 918-23, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26964772
15.
De novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers.
Lung Cancer
; 99: 17-22, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565908
16.
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation.
Lung Cancer
; 90(3): 369-74, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26791794
17.
Correction: EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas.
Clin Cancer Res
; 26(9): 2277, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32358026
18.
Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.
Cancer Treat Commun
; 4: 174-181, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26601054
19.
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.
Lung Cancer
; 88(1): 108-11, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682925
20.
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.
Lung Cancer
; 88(1): 70-3, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25700797